CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-30 | Echerd Margaret SVP, Principal Accntng Officer | Exercise or conversion | +666 | $5.17 | $3K | 666 |
| 2021-11-30 | Echerd Margaret SVP, Principal Accntng Officer | Exercise or conversion | +2,936 | $0.77 | $2K | 3,602 |
| 2021-11-30 | Echerd Margaret SVP, Principal Accntng Officer | Sale | −3,602 | $8.00 | $29K | 0 |
| 2021-11-30 | Echerd Margaret SVP, Principal Accntng Officer | Exercise or conversion · Stock Option (right to buy) | −666 | 1,667 | ||
| 2021-11-30 | Echerd Margaret SVP, Principal Accntng Officer | Exercise or conversion · Stock Option (right to buy) | −2,936 | 26,416 | ||
| 2021-10-12 | Yedid Robert A. Director | Gift | −1,500 | 6,740 | ||
| 2021-10-12 | Yedid Robert A. Director | Gift | −1,500 | 5,240 | ||
| 2021-10-12 | Yedid Robert A. Director | Gift | −1,500 | 3,740 | ||
| 2021-10-12 | Yedid Robert A. Director | Gift | +1,500 | 1,500 | ||
| 2021-09-10 | Echerd Margaret SVP, Principal Accntng Officer | Exercise or conversion | +334 | $5.17 | $2K | 334 |
| 2021-09-10 | Echerd Margaret SVP, Principal Accntng Officer | Exercise or conversion | +1,467 | $0.77 | $1K | 1,801 |
| 2021-09-10 | Echerd Margaret SVP, Principal Accntng Officer | Sale | −1,801 | $9.10 | $16K | 0 |
| 2021-09-10 | Echerd Margaret SVP, Principal Accntng Officer | Exercise or conversion · Stock Option (Right to Buy) | −334 | 2,333 | ||
| 2021-09-10 | Echerd Margaret SVP, Principal Accntng Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,467 | 29,352 | ||
| 2021-08-20 | Cherrington Julie M Director | Grant or award · Stock Option (right to buy) | +65,700 | 65,700 | ||
| 2021-08-10 | Tucker Sean SVP, Chief Scientific Officer | Sale | −4,172 | $10.20 | $43K | 43,881 |
| 2021-08-10 | Tucker Sean SVP, Chief Scientific Officer | Sale | −5,828 | $10.20 | $59K | 51,465 |
| 2021-08-10 | Echerd Margaret SVP, Principal Accntng Officer | Exercise or conversion | +333 | $5.17 | $2K | 333 |
| 2021-08-10 | Echerd Margaret SVP, Principal Accntng Officer | Exercise or conversion | +1,468 | $0.77 | $1K | 1,801 |
| 2021-08-10 | Echerd Margaret SVP, Principal Accntng Officer | Sale | −1,801 | $10.00 | $18K | 0 |
Page 11 of 23 · 442 trades